Conservation of transcriptional regulation by BRCA1 and BARD1 in Caenorhabditis elegans.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
21 03 2023
Historique:
accepted: 29 09 2022
revised: 22 09 2022
received: 14 07 2022
pubmed: 18 10 2022
medline: 21 3 2023
entrez: 17 10 2022
Statut: ppublish

Résumé

The tumor-suppressor proteins BRCA1 and BARD1 function as an E3 ubiquitin ligase to facilitate transcriptional repression and DNA damage repair. This is mediated in-part through its ability to mono-ubiquitylate histone H2A in nucleosomes. Studies in Caenorhabditis elegans have been used to elucidate numerous functions of BRCA1 and BARD1; however, it has not been established that the C. elegans orthologs, BRC-1 and BRD-1, retain all the functions of their human counterparts. Here we explore the conservation of enzymatic activity toward nucleosomes which leads to repression of estrogen-metabolizing cytochrome P450 (cyp) genes in humans. Biochemical assays establish that BRC-1 and BRD-1 contribute to ubiquitylation of histone H2A in the nucleosome. Mutational analysis shows that while BRC-1 likely binds the nucleosome using a conserved interface, BRD-1 and BARD1 have evolved different modes of binding, resulting in a difference in the placement of ubiquitin on H2A. Gene expression analysis reveals that in spite of this difference, BRC-1 and BRD-1 also contribute to cyp gene repression in C. elegans. Establishing conservation of these functions in C. elegans allows for use of this powerful model organism to address remaining questions regarding regulation of gene expression by BRCA1 and BARD1.

Identifiants

pubmed: 36250637
pii: 6761983
doi: 10.1093/nar/gkac877
pmc: PMC10018340
doi:

Substances chimiques

BARD1 protein, human EC 2.3.2.27
BRCA1 Protein 0
brd-1 protein, C elegans 0
Caenorhabditis elegans Proteins 0
Histones 0
Nucleosomes 0
Tumor Suppressor Proteins 0
Ubiquitin-Protein Ligases EC 2.3.2.27
BRC-1 protein, C elegans 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2108-2116

Subventions

Organisme : NCI NIH HHS
ID : R01 CA079953
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA260834
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

J Clin Oncol. 2007 Apr 10;25(11):1329-33
pubmed: 17416853
Nature. 2021 Aug;596(7872):433-437
pubmed: 34321663
Oncogene. 1999 Dec 20;18(55):7900-7
pubmed: 10630642
Cell Rep. 2014 Aug 21;8(4):999-1005
pubmed: 25131202
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1316-1321
pubmed: 29367421
Nature. 2014 Oct 30;514(7524):591-6
pubmed: 25355358
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
J Neurosci. 2021 Mar 31;41(13):2842-2853
pubmed: 33593852
Mol Cell. 2021 Jul 1;81(13):2765-2777.e6
pubmed: 34102105
Nat Commun. 2019 Apr 15;10(1):1751
pubmed: 30988309
Nat Struct Mol Biol. 2007 Oct;14(10):941-8
pubmed: 17873885
G3 (Bethesda). 2019 Jan 9;9(1):135-144
pubmed: 30420468
Nature. 2004 Oct 14;431(7010):873-8
pubmed: 15386022
Methods Enzymol. 2005;399:21-36
pubmed: 16338346
Nat Struct Mol Biol. 2021 Mar;28(3):268-277
pubmed: 33589814
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Nat Commun. 2015 Jul 07;6:7621
pubmed: 26151332
Cancer Res. 2014 May 15;74(10):2773-2784
pubmed: 24638981
Cell Cycle. 2006 Jul;5(14):1481-6
pubmed: 16861894
Genetics. 2020 Oct;216(2):359-379
pubmed: 32796008
PLoS Genet. 2018 Nov 1;14(11):e1007653
pubmed: 30383754
Mol Cell Biol. 2001 May;21(10):3445-50
pubmed: 11313470
Nature. 2011 Sep 07;477(7363):179-84
pubmed: 21901007
Genes Dev. 2019 Apr 1;33(7-8):436-451
pubmed: 30804228
PLoS Genet. 2018 Nov 1;14(11):e1007701
pubmed: 30383767
EMBO J. 2006 May 17;25(10):2178-88
pubmed: 16628214
J Biol Chem. 2016 Jan 1;291(1):182-97
pubmed: 26468281
Genetics. 1974 May;77(1):71-94
pubmed: 4366476
Biochem J. 2021 Sep 30;478(18):3467-3483
pubmed: 34591954
J Biol Chem. 1999 Feb 26;274(9):5659-65
pubmed: 10026184
Nat Commun. 2014;5:3291
pubmed: 24518117
EMBO J. 2011 Jul 19;30(16):3285-97
pubmed: 21772249
Nature. 2021 Aug;596(7872):438-443
pubmed: 34321665
Curr Biol. 2004 Jan 6;14(1):33-9
pubmed: 14711411
Nat Commun. 2021 Aug 18;12(1):5016
pubmed: 34408138
Nat Rev Mol Cell Biol. 2020 May;21(5):284-299
pubmed: 32094664
EMBO Rep. 2008 Mar;9(3):287-92
pubmed: 18219312
J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706
pubmed: 17148771
BMC Biotechnol. 2009 Jun 30;9:61
pubmed: 19566935
J Biosci. 2008 Jun;33(2):269-77
pubmed: 18535361
J Biol Chem. 1998 Apr 3;273(14):7795-9
pubmed: 9525870
Nat Cell Biol. 2019 Mar;21(3):311-318
pubmed: 30804502
Nucleic Acids Res. 2021 Apr 6;49(6):3263-3273
pubmed: 33660782
Int J Biochem Cell Biol. 2016 Mar;72:1-17
pubmed: 26738429

Auteurs

Ishor Thapa (I)

Department of Biology, Texas Christian University, Fort Worth, TX 76129, USA.

Russell Vahrenkamp (R)

Department of Biology, Texas Christian University, Fort Worth, TX 76129, USA.

Samuel R Witus (SR)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

Caitlin Lightle (C)

Department of Biology, Texas Christian University, Fort Worth, TX 76129, USA.

Owen Falkenberg (O)

Department of Biology, Texas Christian University, Fort Worth, TX 76129, USA.

Marlo K Sellin Jeffries (MK)

Department of Biology, Texas Christian University, Fort Worth, TX 76129, USA.

Rachel E Klevit (RE)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

Mikaela D Stewart (MD)

Department of Biology, Texas Christian University, Fort Worth, TX 76129, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH